Literature DB >> 10685629

Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients.

T W Crook1, B B Rogers, R D McFarland, S H Kroft, P Muretto, J A Hernandez, M J Latimer, R W McKenna.   

Abstract

Parvovirus B19 is responsible for a spectrum of disease in humans. The usual bone marrow findings in acute parvovirus infections are marked erythroid hypoplasia and occasional giant erythroblasts. Intranuclear inclusions in developing erythroid precursors are rarely described in children or adults with parvovirus infection, although abundant intranuclear inclusions are commonly observed in the placenta and other tissues in infected fetuses. In this study, 8 patients are reported in whom the first evidence of parvovirus infection was the recognition of numerous intranuclear inclusions in erythroid precursors on bone marrow biopsy sections. Six of the 8 patients had documented immunodeficiencies; 4 had acquired immune deficiency syndrome (AIDS), and 2 were on chemotherapy. Five of 7 patients were negative for immunoglobulin G (IgG) antiparvovirus antibodies, including all 4 with AIDS. Unlike the typical pattern in parvovirus infection, the bone marrow was hypercellular in most of the patients, and erythroid precursors were usually increased with the entire spectrum of normoblast maturation represented; abundant intranuclear inclusions were observed similar to the finding in fetuses. The inclusions were variably eosinophilic and compressed the chromatin against the nuclear membrane. In situ hybridization showed parvovirus B19 DNA in numerous erythroid precursors in all cases. The findings of erythroid maturation and abundant viral inclusions in these immunocompromised patients is consistent with the hypothesis that failure to produce effective IgG parvovirus neutralizing antibodies may lead to persistent infection through viral tolerance that allows erythroid development of infected cells past the pronormoblast stage. Identification of parvovirus inclusions in marrow biopsies and subsequent confirmation of infection by in situ hybridization can be important in the assessment of anemia in immunodeficient patients because serological studies for parvovirus B19 are frequently negative.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10685629     DOI: 10.1016/s0046-8177(00)80215-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Severe anemia.

Authors:  A Shih; R E Kassanoff; B Altrabulsi
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-07

2.  Recurrent severe anaemia: a rare presentation of parvovirus b19 infection.

Authors:  Santokh Singh; Gian Chand; Shiv Charan; Sahil Arora; Parampreet Singh
Journal:  J Clin Diagn Res       Date:  2014-04-15

3.  The co-existence of pure red cell aplasia and autoimmune haemolytic anaemia in a child with malignant lymphoma.

Authors:  Suhair Abbas Ahmed; Rosline Hassan
Journal:  Malays J Med Sci       Date:  2005-07

4.  Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19.

Authors:  T Tolfvenstam; A Oxenius; D A Price; B L Shacklett; H M Spiegel; K Hedman; O Norbeck; M Levi; K Olsen; M Kantzanou; D F Nixon; K Broliden; P Klenerman
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 5.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.